Czasopismo Przewodnik Lekarza 2005

Grypa wskazania do szczepień możliwe powikłania pogrypowe

Lidia B. Brydak, Andrzej F. Steciwko

Przew Lek 2005; 6: 6-9

View text

Atopia pod kontrolą. Rozmowa z prof. Ryszardem Kurzawą

Janusz Michalak

Przew Lek 2005; 6: 14-20

View text

Prevention of cardiovascular diseases in Poland – needs and actual status

Tomasz Zdrojewski

Przew Lek 2005; 6: 23-31

Abstract View text

Metabolic syndrome – epidemic of the 21^st century, a new definition and therapeutic goals

Beata Wożakowska-Kapłon, Radosław Bartkowiak, Alicja Stępień

Przew Lek 2005; 6: 32-38

Abstract View text

Cardiovascular disease prevention – point of view family doctor

Marta E. Starczewska, Arkadiusz Pietrasik, Renata Główczyńska, Krzysztof J. Filipiak, Grzegorz Opolski

Przew Lek 2005; 6: 40-46

Abstract View text

Regional differences in prescription of drugs with proven efficacy in reduction of mortality in secondary prevention of cardiovascular events

Arkadiusz Pietrasik, Marta E. Starczewska, Renata Główczyńska, Krzysztof J. Filipiak, Maciej Łatek, Grzegorz Opolski

Przew Lek 2005; 6: 48-51

Abstract View text

Risk factors of cardiovascular evens in primary care patiens

Renata Główczyńska, Arkadiusz Pietrasik, Marta E. Starczewska, Krzysztof J. Filipiak, Grzegorz Opolski

Przew Lek 2005; 6: 52-57

Abstract View text

Angiotensin II antagonists in heart failure – current recommendations

Marcin Grabowski, Krzysztof J. Filipiak, Grzegorz Opolski

Przew Lek 2005; 6: 58-60

Abstract View text

Cough as an adverse reaction of angiotensin converting enzyme inhibitory

Jarosław Woroń, Ryszard Korbut

Przew Lek 2005; 6: 62-65

Abstract View text

Role of statins in the treatment of heart disease. Heart failure

Maciej Banach, Piotr Okoński

Przew Lek 2005; 6: 66-73

Abstract View text

Aldosterone – underestimated link in the pathogenesis of arterial hypertension

Teresa Kosicka, Hanna Kara-Perz, Wojciech Głuszewski, Stanisław Perz

Przew Lek 2005; 6: 74-80

Abstract View text

High loading dose of clopidogrel in patients undergoing percutaneous coronary intervention

Stefan Grajek, Maciej Lesiak

Przew Lek 2005; 6: 81-89

Abstract View text

Inhaled corticosteroids and long acting β₂-agonists in asthma and chronic obstructive pulmonary disease (COPD)

Anna Doboszyńska

Przew Lek 2005; 6: 90-95

Abstract View text

Herpes simplex viruses – clinical course of infection and therapy

Magdalena Figlerowicz

Przew Lek 2005; 6: 96-103

Abstract View text

Lokomotywa przyszłości

Przew Lek 2005; 6: 105-106

Abstract View text

Będąc młodą lekarką w afrykańskiej wiosce

Anna Wojtacha

Przew Lek 2005; 6: 107-110

View text

Grypa wskazania do szczepień możliwe powikłania pogrypowe

Atopia pod kontrolą. Rozmowa z prof. Ryszardem Kurzawą

Prevention of cardiovascular diseases in Poland – needs and actual status

Metabolic syndrome – epidemic of the 21st century, a new definition and therapeutic goals

Cardiovascular disease prevention – point of view family doctor

Regional differences in prescription of drugs with proven efficacy in reduction of mortality in secondary prevention of cardiovascular events

Risk factors of cardiovascular evens in primary care patiens

Angiotensin II antagonists in heart failure – current recommendations

Cough as an adverse reaction of angiotensin converting enzyme inhibitory

Role of statins in the treatment of heart disease. Heart failure

Aldosterone – underestimated link in the pathogenesis of arterial hypertension

High loading dose of clopidogrel in patients undergoing percutaneous coronary intervention

Inhaled corticosteroids and long acting β2-agonists in asthma and chronic obstructive pulmonary disease (COPD)

Herpes simplex viruses – clinical course of infection and therapy

Lokomotywa przyszłości

Będąc młodą lekarką w afrykańskiej wiosce

Integrated with

Metabolic syndrome – epidemic of the 21^st century, a new definition and therapeutic goals

Inhaled corticosteroids and long acting β₂-agonists in asthma and chronic obstructive pulmonary disease (COPD)